Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer

Structure activity relationships of anthranilic acid-based compounds on cellular and in vivo mitogen activated protein kinase-5 signaling pathways

(2018) Suravi Chakrabarty et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Epithelial to mesenchymal transition induces stem cell like phenotype in renal cell carcinoma cells

(2018) Mamta Singla et al.   Cancer Cell International

Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design

(2018) Nicholas A. Meanwell   JOURNAL OF MEDICINAL CHEMISTRY

Dual role of Par-4 in abrogation of EMT and switching on Mesenchymal to Epithelial Transition (MET) in metastatic pancreatic cancer cells

(2018) Archana Katoch et al.   MOLECULAR CARCINOGENESIS

Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail

(2018) Zhengxi Wei et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

New insights into the role of EMT in tumor immune escape

(2017) Stéphane Terry et al.   Molecular Oncology

Upholding a role for EMT in breast cancer metastasis

(2017) Xin Ye et al.   NATURE

On the role of mechanics in driving mesenchymal-to-epithelial transitions

(2017) Hye Young Kim et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Epithelial–mesenchymal transition: a new target in anticancer drug discovery

(2016) Fabrizio Marcucci et al.   NATURE REVIEWS DRUG DISCOVERY

Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability

(2016) D. R. Pattabiraman et al.   SCIENCE

Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1

(2016) Byong-Ki Cha et al.   Oncotarget

Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells

(2016) Mikiro Takaishi et al.   PLoS One

Applications of Fluorine in Medicinal Chemistry

(2015) Eric P. Gillis et al.   JOURNAL OF MEDICINAL CHEMISTRY

Allosteric small-molecule kinase inhibitors

(2015) Peng Wu et al.   PHARMACOLOGY & THERAPEUTICS

Epithelial to Mesenchymal Transition in a Clinical Perspective

(2015) Jennifer Pasquier et al.   Journal of Oncology

Fluorine as a Hydrogen-Bond Acceptor: Experimental Evidence and Computational Calculations

(2014) Claudio Dalvit et al.   CHEMISTRY-A EUROPEAN JOURNAL

Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways

(2014) Xiaofeng Dong et al.   PLoS One

Targeting EMT in cancer: opportunities for pharmacological intervention

(2014) Felicity M. Davis et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

A pickup in pseudokinase activity

(2013) Arvin C. Dar   BIOCHEMICAL SOCIETY TRANSACTIONS

Dawn of the dead: protein pseudokinases signal new adventures in cell biology

(2013) Patrick A. Eyers et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Tamoxifen Resistance in Breast Cancer

(2012) Min-Sun Chang   Biomolecules & Therapeutics

Triple negative breast cancer: unmet medical needs

(2010) Sumanta Kumar Pal et al.   BREAST CANCER RESEARCH AND TREATMENT

Treatment of triple negative breast cancer (TNBC): current options and future perspectives

(2010) M. De Laurentiis et al.   CANCER TREATMENT REVIEWS

Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer

(2009) Carey K. Anders et al.   Clinical Breast Cancer

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition

(2008) Anne-Pierre Morel et al.   PLoS One